In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...

Alcohol is a known diuretic, and along with the substantial sweating during a run, this raises the likelihood of dehydration and electrolyte imbalance. The potential consequences range from cramps and ...

Dr. Ayo presents his final in the series of Heart and Stroke month preventative care tips in Part 6 during Heart and Stroke awareness ...

The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

Have you ever wondered if exercise makes people live longer or if people who are going to live longer are the same people who ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

Among patients with isolated systolic hypertension and frailty, antihypertensive therapy is associated with improved outcomes.